when does the semaglutide patent expire Ozempic, Wegovy and Rybelsus: patents behind Novo Nordisk's weight-loss drugs Ozempic's Patent Protection Starts to

In usual nutritional doses, they are generally considered compatible with breastfeeding, but higher or prolonged supplemental doses should only be used on medical advice

Cork also told BBC Science Focus that "we don't have any data on the long-term safety of this drug." Suicide risk In July 2023, the European Medicines Agency announced it is reviewing data on the potential risk of suicidal thoughts and thoughts of self-harm associated with GLP-1 medicines, including Ozempic and Wegovy

Pablo Rivera-Fuentes: Writing review & editing, Writing original draft, Validation, Methodology, Investigation, Formal analysis, Conceptualization

Am J Ment Retard 2004

Yassin et al., 2025